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Abstract The cAMP-dependent protein kinase A (PKA) regulates various cellular functions in
health and disease. In endothelial cells PKA activity promotes vessel maturation and limits tip cell
formation. Here, we used a chemical genetic screen to identify endothelial-specific direct
substrates of PKA in human umbilical vein endothelial cells (HUVEC) that may mediate these
effects. Amongst several candidates, we identified ATG16L1, a regulator of autophagy, as novel
target of PKA. Biochemical validation, mass spectrometry and peptide spot arrays revealed that
PKA phosphorylates ATG16L1a at Ser268 and ATG16L1b at Ser269, driving phosphorylation-
dependent degradation of ATG16L1 protein. Reducing PKA activity increased ATG16L1 protein
levels and endothelial autophagy. Mouse in vivo genetics and pharmacological experiments
demonstrated that autophagy inhibition partially rescues vascular hypersprouting caused by PKA
deficiency. Together these results indicate that endothelial PKA activity mediates a critical switch
from active sprouting to quiescence in part through phosphorylation of ATG16L1, which in turn
reduces endothelial autophagy.
DOI: https://doi.org/10.7554/eLife.46380.001
Introduction
Angiogenesis is the process of new blood vessels formation from pre-existing vessels via sprouting
and remodeling. Blood vessels are crucial for tissue growth and physiology in vertebrates since they
are the pipelines for oxygen and nutrients supply and for immune cell distribution. Inadequate vessel
formation and maintenance as well as abnormal vascular remodeling cause, accompany or aggravate
many disease processes including myocardial infarction, stroke, cancer, and inflammatory disorders
(Geudens and Gerhardt, 2011; Potente et al., 2011).
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Sprouting angiogenesis is a multistep process encompassing sprout initiation, elongation, anasto-
mosis and final vascular network formation (Geudens and Gerhardt, 2011). Multiple molecular path-
ways have been identified to regulate sprouting angiogenesis; the most investigated are vascular
endothelial growth factor (VEGF) and Notch/delta-like 4 (DLL4) signaling. Whereas VEGF initiates
angiogenesis through activating VEGF receptor 2 (VEGFR2), thereby guiding angiogenic sprouting
and tip cell formation as well as stalk cell proliferation (Ferrara et al., 2003; Gerhardt et al., 2003),
Notch and its ligand delta-like 4 (DLL4) limit tip cell formation and angiogenic sprouting
(Hellstro¨m et al., 2007; Leslie et al., 2007; Lobov et al., 2007; Suchting et al., 2007). VEGF and
Notch/DLL4 pathways co-operate to form a fine-tuned feedback loop to balance tip and stalk cells
during developmental angiogenesis and to maintain vascular stabilization (Hellstro¨m et al., 2007;
Leslie et al., 2007; Lobov et al., 2007; Suchting et al., 2007). In addition, PI3K/Akt (Lee et al.,
2014), MAP4K4 (Vitorino et al., 2015), ephrins and Eph receptors (Cheng et al., 2002), hedgehog
signaling (Pola et al., 2001),YAP/TAZ (Kim et al., 2017; Neto et al., 2018),BMP signaling
(Vion et al., 2018) and other pathways also regulate various aspects of angiogenesis.
We identified endothelial cAMP-dependent protein kinase A (PKA) as a critical regulator of angio-
genesis during vascular development in vivo. Inhibition of endothelial PKA results in hypersprouting
and increased numbers of tip cells, indicating that PKA regulates the transition from sprouting to
quiescent vessels (Nedvetsky et al., 2016). However, the PKA targets mediating these effects
remained unknown.
Here, we established a chemical genetics approach based on the mutation of a ‘gatekeeper resi-
due’ of the ATP-binding pocket of a protein kinase to identify endothelial-specific substrates of PKA.
We verified autophagy-related-protein-16-like 1 (ATG16L1) as a substrate of endothelial PKA and
identified that phosphorylation of ATG16L1 facilitates its degradation. in vivo experiments showed
that autophagy inhibition partially rescued the hypersprouting and increased tip cell numbers caused
by PKA deficiency.
Results
Screen for novel substrates of endothelial PKA
In order to identify direct substrates of endothelial PKA, we employed a chemical genetics approach
(Allen et al., 2005). The ATP-binding pocket of kinases contains a conserved ‘gatekeeper residue’,
which in naturally occurring wild type (WT) kinases is usually a methionine or phenylalanine. In engi-
neered analogue specific (AS) kinases, this ‘gatekeeper residue’ is replaced with a smaller amino
acid (glycine or alanine), enabling the AS-kinases to accept ATP analogues (or ATPgS analogues)
that are modified at the N6 position with bulky groups as (thio-)phosphodonors. In contrast, WT-kin-
ases poorly use these analogues. Once the substrates are thiophosphorylated by AS-kinases, they
can be further alkylated and therefore recognized by a thiophosphate ester-specific antibody
(Alaimo et al., 2001; Allen et al., 2005; Allen et al., 2007; Banko et al., 2011). To generate AS-
PKACa, we mutated the methionine 120 to a glycine residue. Testing seven different variants of N6-
substituted bulky ATPgS analogues, we identified 6-cHe-ATPgS as the best thiophosphodonor for
AS-PKACa substrates in HUVEC lysates (Figure 1—figure supplement 1).
To identify endothelial substrates of PKACa, HUVECs expressing WT-PKACa or AS-PKACa were
lysed in kinase lysis buffer (KLB) and the thiophosphorylation reaction with 6-cHe-ATPgS was per-
formed. After alkylation with p-Nitrobenzyl mesylate (PNBM), thiophosphorylated proteins were
immunoprecipitated with the thioP antibody coupled to rProtein G Agarose beads (Figure 1A). For
quality control, one thirtieth of the protein on agarose beads was eluted for western blot analysis,
and the same amount of protein was used for gel silver staining (Figure 1B). The rest was subjected
to mass spectrometry analysis. Two independent experiments were performed. Candidate endothe-
lial PKA targets were identified as peptides that were at least 2-fold (log ratio(AS/WT)>1) enriched
in the AS-PKACa samples compared to WT- PKACa samples in both experiments.
The ninety-seven proteins identified in both experiments (Table 1—source data 1) included sev-
eral known PKA substrates such as NFATC1 (Niswender et al., 2002), VASP (Anton et al., 2014;
Butt et al., 1994; Profirovic et al., 2005), PRKAR2A and PRKAR2B (Manni et al., 2008) indicating
that the chemical genetic screen worked well to identify PKA substrates. Thirty proteins with at least
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Figure 1. Identification of direct substrates of PKACa. (A) Strategy for labeling, immunoprecipitation and identifying of PKACa substrates in HUVEC
lysates. (B) Thio-phosphorylation of PKA substrates in HUVEC lysates expressing WT-PKACa or AS-PKACa for mass spectrometry analysis. Left panel
(input) shows western blot analysis of lysates after alkylation before immunoprecipitation, middle panel (Eluate) shows western blot analysis of the
eluted proteins from the immunoprecipitation beads, right panel (Eluate) shows the silver staining of the same samples as middle panel. (C) Validation
of the six PKACa substrates identified in the chemical genetic approach screen by overexpressing of potential substrates and WT-PKACa (or AS-
PKACa) in 293Tcells, and labeling the substrate in 293 T cell lysates. Western blots are representative of two independent experiments.
DOI: https://doi.org/10.7554/eLife.46380.002
The following figure supplement is available for figure 1:
Figure supplement 1. Screen for the best N6-substituted ATPgS analog as a phosphodonor of AS-PKACa.
DOI: https://doi.org/10.7554/eLife.46380.003
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8-fold enrichment (log ratio(AS/WT)>3) are listed according to their log ratio (AS/WT) value in
Table 1, presenting the most likely direct substrates of PKA in this screen.
To validate novel candidate PKACa substrates, we overexpressed WT-PKACa or AS-PKACa
together with flag- or GFP- tagged candidate proteins in 293 T cells, and used the 6-cHe-ATPgS as
Table 1. List of PKACa substrates.
Proteins are listed according to the log of fold changes of AS-PKACa to WT- PKACa. Two independent experiments have been done
to prepare the PKACa substrates samples for mass spectrometric analysis.
Uniprot Protein.names Gene.names Peptides
Log ratio AS/WT
experiment1 experiment2
Q6AI12 Ankyrin repeat domain-containing protein 40 ANKRD40 9 10 10
Q6P6C2 RNA demethylase ALKBH5 ALKBH5 6 10 10
Q9NRY4 Rho GTPase-activating protein 35 ARHGAP35 9 10 10
E7EVC7 Autophagy-related protein 16–1 ATG16L1 8 10 10
J3KPC8 Serine/threonine-protein kinase SIK3 SIK3;KIAA0999 5 10 10
A1  283 SH3 and PX domain-containing protein 2B SH3PXD2B 4 10 10
Q8IWZ8 SURP and G-patch domain-containing protein 1 SUGP1 5 10 10
Q9UJX5 Anaphase-promoting complex subunit 4 ANAPC4 5 10 10
O43719 HIV Tat-specific factor 1 HTATSF1 4 10 10
O95644-5 Nuclear factor of activated T-cells, cytoplasmic 1 NFATC1 5 10 10
G8JLI6 Prolyl 3-hydroxylase 3 LEPREL2 3 10 10
F8W781 Zinc finger CCCH domain-containing protein 13 ZC3H13 3 10 10
Q9BZL4 Protein phosphatase 1 regulatory subunit 12C PPP1R12C 21 6,04440274 7,30701515
O14974 Protein phosphatase 1 regulatory subunit 12A PPP1R12A 26 5,72796034 7,12654716
Q00537 Cyclin-dependent kinase 17 CDK17 31 6,37867381 6,39216838
Q9Y4G8 Rap guanine nucleotide exchange factor 2 RAPGEF2 21 10 6,17455504
Q9BYB0 SH3 and multiple ankyrin
repeat domains protein 3
SHANK3 32 5,26591421 5,6389181
J3KSW8 Myosin phosphatase Rho-interacting protein MPRIP 18 4,61398477 5,61155414
P31323 cAMP-dependent protein kinase
type II-beta regulatory subunit
PRKAR2B 19 7,05077105 5,33509437
P13861 cAMP-dependent protein kinase
type II-alpha regulatory subunit
PRKAR2A 24 5,42841998 5,04010629
Q14980-2 Nuclear mitotic apparatus protein 1 NUMA1 61 3,45625969 4,47466712
O15056 Synaptojanin-2 SYNJ2 13 4,64022655 4,46069701
J3KNX9 Unconventional myosin-XVIIIa MYO18A 10 10 4,43208178
Q86UU1-2 Pleckstrin homology-like domain
family B member 1
PHLDB1 19 5,4105243 4,10782285
P28715 DNA repair protein complementing XP-G cells ERCC5;BIVM-ERCC5 8 3,3571826 4,09305592
P12270 Nucleoprotein TPR TPR 104 3,3333472 4,04477536
Q15111 Inactive phospholipase C-like protein 1;
Phosphoinositide phospholipase C
PLCL1 10 10 3,32188704
Q9HD67 Unconventional myosin-X MYO10 39 4,13973415 3,21827463
Q14185 Dedicator of cytokinesis protein 1 DOCK1 34 4,50413426 3,18515106
O75116 Rho-associated protein kinase 2 ROCK2 29 3,27701864 3,08277835
DOI: https://doi.org/10.7554/eLife.46380.004
The following source data is available for Table 1:
Source data 1. The full list of proteins identified in both experiments is provided.
DOI: https://doi.org/10.7554/eLife.46380.005
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thiophosphate donor to thiophosphorylate substrates in lysates as described above. Lysate immuno-
precipitation was carried out with M2 anti-flag beads or anti-GFP antibody coupled agarose beads,
and the immune complexes were probed by western blot using thiophosphate antibody. The known
PKA substrate NFATC1 served as a positive control. Five selected new candidate proteins
(PPP1R12C, ATG16L1a, DDX17, ANKRD40 and ATG5) out of ninety-seven proteins were tested;
four of these five proteins were confirmed to be thiophosphorylated by AS-PKACa, indicating that
they are indeed direct substrates of AS-PKACa (Figure 1C). Only ATG5 was not thiophosphorylated
by AS-PKACa in the validation of the screen (Figure 1C). Bioinformatic analysis of ATG5 amino acids
sequence also failed to identify a consensus PKA substrate motif (R-R/K-X-S/T;K/R-X1-2-S/T)
(Kennelly and Krebs, 1991). Since ATG5 directly binds to ATG16L1 (Matsushita et al., 2007;
Mizushima et al., 1999), it likely co-precipitated with ATG16L1 in our screen.
ATG5 and ATG16L1 are conserved core components of the autophagy process, and PKA activity
has been shown to negatively regulate autophagy in S. Cervisiae and mammalian cells through phos-
phorylation of ATG1/ULK1 (Mizushima, 2010). ATG16L1 however has not previously been identified
as a PKA target, prompting us to further investigate this interaction and the potential regulatory role
of PKA and autophagy in endothelial sprouting.
Pkaca phosphorylates ATG16L1a at S268 and ATG16L1b at S269
To identify the PKACa phosphorylation sites in ATG16L1, we spot-synthesized 25-mer overlapping
peptides that cover the entire ATG16L1 protein. The peptide array was subjected to an in vitro PKA
phosphorylation assay. Three peptides of the ATG16L1a and 7 peptides of ATG16L1b were phos-
phorylated compared to the negative control (Figure 2A, Supplementary file 1). The common
amino acid sequences included in the phosphorylated peptides predicted Ser268 in ATG16L1a and
Ser269 as well as Ser287 in ATG16L1b as potential PKA phosphorylation sites (Figure 2B). Indeed
serine to alanine mutation S268A in ATG16L1a and S269A but not S287A mutation in ATG16L1b
resulted in a loss of AS-PKACa thiophosphorylation of these two ATG16L1 isoforms (Figure 2C and
D). Moreover, LC-MS/MS analysis demonstrated phosphorylation of ATG16L1a at S268 and of
ATG16L1b at S269 (Figure 2E and F). Of note, thiophosphorylation was converted to normal phos-
phorylation by 1% TFA acid-catalyzed hydrolysis during sample preparation for LC-MS/MS, thus
identifying the target sites as phosphorylated, not thiophosphorylated (Figure 2—figure supple-
ment 1). Together, these results demonstrate that S268 and S269 are the PKACa phosphorylation
sites of ATG16L1a and ATG16L1b, respectively.
Pkaca regulates ATG16L1 by phosphorylation-dependent degradation
Phosphorylation is one of the most widespread types of post-translational modification, and is crucial
for signal transduction (Hunter, 1995; Manning et al., 2002; Ubersax and Ferrell, 2007). Previous
research demonstrated that phosphorylation can regulate protein degradation by controlling its sta-
bilization (Bullen et al., 2016; Geng et al., 2009; Hwang et al., 2009). To determine whether phos-
phorylation of ATG16L1a by PKA regulates protein stability, we overexpressed ATG16L1aWT and
the mutant ATG16L1aS268A in HUVECs. To activate PKA, HUVECs were treated with the PKA specific
activator 6-Bnz-cAMP. Using cycloheximide (CHX) to prevent new protein synthesis allowed us to
detect the degradation of ATG16L1aWT and ATG16L1aS268A over time. Western blot analysis
showed that most of the ATG16L1aWT degraded after 12 hr, whereas ATG16L1aS268A remained
largely stable (Figure 3A), suggesting that the phosphorylation of ATG16L1a at site Ser268 by PKA
promotes degradation. For ATG16L1b, Ser269 phosphorylation exhibited a similar function
(Figure 3B). In addition, the phosphomimetic site mutants ATG16L1aS268D and ATG16L1bS269D were
less stable than wild type ATG16L1a and ATG16L1b (Figure 3C–3D), supporting the idea that phos-
phorylation of ATG16L1a on site S268 and ATG16L1b on site S269 by PKA promotes degradation.
In accordance, depleting PKACa in HUVECs by shRNA led to accumulation of ATG16L1 (Figure 3E)
whereas activating PKA by 6-Bnz-cAMP caused ATG16L1 reduction (Figure 3F). Moreover, in PKA
inhibited endothelial cells isolated from dnPKAiEC mice (Nedvetsky et al., 2016), ATG16L1 protein
was also increased compared to endothelial cells isolated from corresponding Cdh5-CreERT2 con-
trol mice (Figure 3G). dnPKAiEC is the short denomination for Prkar1aTg/+ mice carrying a single
floxed dominant-negative Prkar1a allele, (the regulatory subunit Prkar1a of PKA is an endogenous
inhibitor of PKA) crossed with Cdh5-CreERT2 mice expressing tamoxifen inducible Cre recombinase
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 5 of 25
Research article Biochemistry and Chemical Biology Cell Biology
Figure 2. PKACa phosphorylates ATG16L1a at S268 and ATG16L1b at S269. (A) Peptide SPOT assay of ATG16L1 phosphorylation sites screening. (B)
Amino acid sequence including potential PKACa phosphorylation sites in ATG16L1a and ATG16L1b according to the peptide SPOT assay result of
Figure 2A. (C–D) Identification of PKACa phosphorylation site in ATG16L1a (C) and ATG16L1b (D). Analysis was performed as in Figure 1C. Western
blots are representative of two independent experiments. (E–F) Flag tagged ATG16L1a and ATG16L1b were thio-phosphorylated by AS-PKACa and
Figure 2 continued on next page
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under control of endothelial specific Cdh5 promotor (Nedvetsky et al., 2016). Taken together,
these results indicate that PKACa regulates ATG16L1 by phosphorylation-dependent degradation.
Inhibition of autophagy partially normalizes the vascular phenotype
caused by PKA-deficiency
ATG16L1 is an important component of the ATG16L1-ATG5-ATG12 protein complex, required for
LC3 lipidation and autophagosome formation. Both LC3 lipidation and autophagosome formation
represent essential steps in autophagy (Kuma et al., 2002; Levine and Kroemer, 2008;
Matsushita et al., 2007; Mizushima et al., 2003; Mizushima et al., 1999). Accumulation of
ATG16L1 upon PKA knock down resulted in increased levels of the positive autophagy marker LC3II
whilst reducing the negative autophagy marker p62 in HUVECs (Figure 3E) whereas depleting
ATG16L1 by 6-Bnz-cAMP mediated PKA activation resulted in decreased levels of LC3II whilst
increasing p62 in HUVECs (Figure 3F). Since ATG16L1 protein levels in endothelial cells isolated
from dnPKA mice were also increased, we hypothesized that increased autophagy in endothelial
cells may contribute to the vascular phenotype in these mice. If so, inhibiting autophagy could
potentially normalize vascular hypersprouting in dnPKAiEC mice. To test this hypothesis, we crossed
the ATG5 conditional knock out mice ATG5ECKO (ATG5flox/flox mice crossed with Cdh5-CreERT2
mice) with dnPKAiEC mice, performed retinal staining for isolectin B4 (IB4, membrane staining) and
the tip cell specific marker ESM1, and quantified the IB4 and ESM1 positive areas. No significant dif-
ference were observed between Cdh5-CreERT2 control mice and ATG5ECKO mice on both the vascu-
lar plexus and tip cells. However, ATG5ECKO partially rescued both the hyperdense vascular plexus
front and the increasing tip cells in dnPKAiEC mice. Retinal stainings demonstrated that ATG5 dele-
tion in endothelial cells in vivo, which shuts down ATG5-dependent autophagy, partially normalizes
the hypersprouting phenotype of dnPKAiEC mice (Figure 4A–4F). Autophagy inhibitor chloroquine
(CQ) treatment confirmed that autophagy inhibition can partially rescue both the hyperdense vascu-
lar plexus front and the increasing tip cells in dnPKAiEC mice (Figure 4—figure supplement 1) . Fur-
ther more, although the ratio of proliferating endothelial cells was not significant different in retinas
of the four groups of mice (Cdh5-CreERT2 control; ATG5ECKO;dnPKAiEC; and dnPKAiEC ATG5ECKO),
the total number of endothelial cells and proliferating endothelial cells was deceased in dnPKAiEC
ATG5ECKO compared to dnPKAiEC mouse retinas (Figure 5A–5D). Also the low levels of apoptotic
endothelial cells showed no significant differences (Figure 5E–5F), suggesting that neither the rate
of proliferation nor the frequency of apoptosis are drivers of PKA and ATG5 dependent vascular
density and sprouting phenotypes. ATG5 deletion in endothelial cells instead appears to normalize
the hypersprouting phenotype of dnPKAiEC mice by reducing the number of endothelial tip cells
cells as well as the total number of proliferating endothelial cells. Although speculative at this time,
a shorter cell cycle or more rounds of cycling per cell in the case of increased autophagy would for
example explain the increased number of cells with unchanged ratio of proliferating endothelial
cells. Altogether our results suggest that PKA regulates the switch from sprouting to stabilization of
nascent vascular plexuses by limiting endothelial autophagy levels via ATG16L1 degradation.
Discussion
Our chemical genetic screen and biochemical analysis identified ATG16L1 as a novel target of PKA
activity in endothelial cells. The combined results demonstrate that PKA activity inhibits autophagy
in cultured human umbilical vein endothelial cells (HUVEC) via the phosphorylation of ATG16L1,
which accelerates its degradation. In cultured bovine aortic endothelial cells, induction of autophagy
Figure 2 continued
purified twice using M2 beads and thioP antibody coupled beads, followed by mass spectrometric analysis. LC-MS/MS spectra of the PKA-
phosphorylated ATG16L1a tryptic peptide pSVSSFPVPQDNVDTHPGSGK and ATG16L1b tryptic peptide RLpSQPAGGLLDSITNIFGR. The results
demonstrate that PKA phosphorylated ATG16L1a at S268 and phosphorylated ATG16L1b at S269.
DOI: https://doi.org/10.7554/eLife.46380.006
The following figure supplement is available for figure 2:
Figure supplement 1. Thiophophorylation is converted to normal phosphoryation by 1% TFA acid–promoted hydrolysis.
DOI: https://doi.org/10.7554/eLife.46380.007
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Figure 3. PKACa mediated phosphorylation of ATG16L1 facilitates its degradation whereas PKA deficiency stabilizes ATG16L1. (A–A’’) HUVECs
infected with Flag ATG16L1a (WT or S268A) were treated with 250 mM 6-bnz-cAMP and 20 mg/ml CHX at the time points indicated when they reached
confluence (A). Quantifications of Flag ATG16L1a WT (A’) and S268A (A’’) expression. (B–B’’) HUVECs infected with Flag ATG16L1b (WT or S269A) were
treated with 250 mM 6-bnz-cAMP and 20 mg/ml CHX at the time points indicated when they reached confluence (B). Quantifications of Flag ATG16L1b
Figure 3 continued on next page
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by overexpression of ATG5 has been shown to promote in vitro vascular tubulogenesis, whereas
ATG5 silencing suppressed this morphogenic behavior (Du et al., 2012). In mice, inhibition of
autophagy by bafilomycin, or genetic beclin heterozygosity as well as ATG5 knockout impairs angio-
genesis post myocardial infarction, whereas the angiogenic factor AGGF1 enhances therapeutic
angiogenesis through JNK-mediated stimulation of endothelial autophagy (Lu et al., 2016). Angio-
genesis during tissue regeneration in a burn wound model also relied on induction of endothelial
autophagy, by driving AMPK/AKT/mTOR signaling (Liang et al., 2018), together suggesting that
autophagy regulation may represent a critical determinant of the extent of vascular sprouting. The
identification of ATG16L1 as a direct target of PKA therefore raises the hypothesis that the dramatic
hypersprouting phenotype in dnPKAiEC mouse retinas deficient in endothelial PKA activity may result
from exuberant endothelial activation of autophagy. Both genetic endothelial inactivation of ATG5
and chemical inhibition of autophagy partially normalized the hypersprouting phenotype in dnPKAiEC
mice, suggesting that indeed the activation of autophagy in dnPKAiEC mice contributes to vascular
hypersprouting. However, the failure to fully normalize vascular patterning by autophagy inhibition
indicates that additional PKA targets and mechanisms may be involved. Our mass spectrometry anal-
ysis identified a list of presumptive endothelial PKA substrates, which will potentially also be involved
in angiogenesis. For example, we identified RAPGEF2 as a candidate target, deficiency of which
causes embryonic lethality at E11.5 due to yolk sac vascular defects (Satyanarayana et al., 2010),
very similar to the yolk sac phenotype in dnPKAiEC embryos (Nedvetsky et al., 2016). Similarly the
potential target Rock2 has a well known role in regulating endothelial functions in angiogenesis
(Liu et al., 2018; Montalvo et al., 2013; Seto et al., 2016; Shimizu et al., 2013). Further studies
will need to validate all the listed targets and establish which of these exert critical endothelial func-
tions, and under what conditions.
An alternative explanation for the partial rescue of the dnPKAiEC phenotype by inhibition of
autophagy could lie in additional functions of ATG16L1 itself. Although ATG16L1 plays an essential
role in autophagy, and is part of a larger protein complex ATG16L1-ATG5-ATG12 that is necessary
for autophagy, ATG16L1 is also involved in the production of inflammatory cytokines IL-1b and IL-18
and exerts anti-inflammatory functions during intestinal inflammation (Cadwell et al., 2008;
Diamanti et al., 2017; Saitoh et al., 2008; Sorbara et al., 2013). IL-1b promotes angiogenesis by
activating VEGF production during tumor progression (Carmi et al., 2013; Voronov et al., 2003),
while IL-18 suppresses angiogenesis in cancer (Cao et al., 1999; Xing et al., 2016; Yang et al.,
2010). How ATG16L1 regulates angiogenesis through inflammatory cytokines and whether this regu-
lation operates downstream of PKA activity in vivo requires further investigation.
Intriguingly, our rescue experiments show that in wild type mice, inhibition of autophagy has no
significant effect on developmental retinal angiogenesis. This could indicate that autophagy in devel-
opmental angiogenesis, unlike in pathological angiogenesis and post-ischemic tissue responses, is
not very active.
Although, to our knowledge, this is the first identification of ATG16L1 as a PKA target and the
first indication that PKA regulates autophagy in endothelial cells, PKA has previously been identified
as regulator of autophagy. For example, PKA reduces autophagy through phosphorylation of
Figure 3 continued
WT (B’) and S269A (B’’) expression. (C–C’’) HUVECs infected with GFP ATG16L1a (WT or S268D) were treated with 20 mg/ml CHX at the time points
indicated when they reached confluence (C). Quantifications of GFP ATG16L1a WT (C’) and S268D (C’’) expression. (D–D’’) HUVECs infected with GFP
ATG16L1b (WT or S269D) were treated with 20 mg/ml CHX at the time points indicated when they reached confluence (D). Quantifications of GFP
ATG16L1b WT (D’) and S269D (D’’) expression. (E–E’) HUVECs infected with shRNA (scramble or shPKACa) virus were lysed in RIPA buffer and proteins
were analyzed by western blot using indicated antibodies (E). Quantifications of indicated protein expression (E’). (F–F’) HUVECs treated with
DMSO (control) and 500 mM 6-bnz-cAMP were lysed in RIPA buffer and proteins were analyzed by western blot using indicated antibodies (F).
Quantifications of indicated protein expression (F’). (G–G’) Endothelial cells isolated from mice (wild type or dnPKAiEC) were lysed in RIPA buffer and
ATG16L1 protein was analyzed by western blot (G). Quantifications of indicated ATG16L1 expression (G’). Data present the mean ± SD of 3
independent experiments. *P<0,05; **P<0,01; ***P<0,001; ****P<0,0001.
DOI: https://doi.org/10.7554/eLife.46380.008
The following source data is available for figure 3:
Source data 1. Values for quantification of indicated protein expression in Figure 3A, B, C, D, E, F and G.
DOI: https://doi.org/10.7554/eLife.46380.009
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Figure 4. Autophagy inhibition partially rescues retinal vascular hypersprouting caused by PKA deficiency. (A–F) Mice were injected with tamoxifen
from P1 to P3, then retinas were collected at P6. Isolectin B4 and ESM1 staining of P6 retinas isolated from wtPKA with wtATG5 or ATG5ECKO mice and
dnPKAiEC with wtATG5 or ATG5ECKO mice. Representative images are shown (A,D). Quantifications of radial expansion (B), sprouts per 100mm (C),
Figure 4 continued on next page
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ATG13 in Saccharomyces cerevisiae (Hundsrucker et al., 2006), and through phosphorylation of
LC3 in neurons (Cherra et al., 2010). In our research, ATG16L1 was identified as a novel direct PKA
substrate in endothelial cells, but not ATG13 or LC3. Mechanistically, the phosphorylation of
ATG16L1 by PKA accelerates its degradation, and consequently decreases autophagy levels in endo-
thelial cells. The finding of different components of the autophagy pathway as targets of PKA identi-
fied in yeast and various vertebrate cell populations raises the intriguing possibility that although the
principle regulatory logic of PKA in autophagy is conserved, different protein targets mediate this
effect in different cells or organisms. In addition, or alternatively, this regulation carries multiple lev-
els of redundancy, and the individual studies simply identify the most prevalent targets within the
respective cell types. The fact that also ATG16L1 comes in two splice variants that are both targeted
by PKA in endothelial cells lends some strength to this idea.
Interestingly, ATG16L1 can itself be regulated by multiple phosphorylation events by distinct kin-
ases, with opposing effects on protein stability and autophagy. ATG16L1 can be phosphorylated at
Ser139 by CSNK2 and this phosphorylation enhances its interaction with the ATG12-ATG5 conjugate
(Song et al., 2015). IKKa promotes ATG16L1 stabilization by phosphorylation at Ser278
(Diamanti et al., 2017). In addition, phospho-Ser278 has similar functions as phospho-Thr300, since
both phospho-mutants ATG16L1S278A and ATG16L1T300A accelerate ATG16L1 degradation by
enhancing caspase three mediated ATG16L1 cleavage (Diamanti et al., 2017; Murthy et al., 2014).
In contrast, our finding suggest that the PKA target sites Ser268 in ATG16L1a (or Ser269 in
ATG16L1b) work in the opposite way of Ser278 and Thr300; ATG16L1aS268A (and ATG16L1bS269A)
are more stable than ATG16L1WT. Furthermore, PKA deficiency also stabilizes ATG16L1 in endothe-
lial cells in vivo and in vitro. Taken together, it appears that the different phosphorylation sites of
ATG16L1 play different roles in fine tuning protein stability under the influence of alternative
upstream kinases, and thereby adapt autophagy levels. Given the increasing insights into the role of
autophagy in cell and tissue homeostasis and in disease, it will be of great interest to investigate
whether the newly identified regulation by PKA extends beyond developmental angiogenesis into
pathomechanisms associated with endothelial dysfunction.
Finally, on a technical note, the chemical genetics approach developed by Shokat and colleagues
(Alaimo et al., 2001; Allen et al., 2005; Allen et al., 2007) has successfully been used in other cell
types, but to our knowledge, this is the first report on direct endothelial PKA targets. Our initial
attempts using published cell lysate conditions based on RIPA buffer however failed to identify dif-
ferences in thiophosphorylation when comparing AS-PKA expressing cells to WT-PKA expressing
cells. Our buffer optimization revealed that RIPA buffer limits the activity of PKA, whereas our new
kinase lysis buffer (see Materials and methods) allows effective substrate phosphorylation, thus giv-
ing rise to strong signals in AS-PKA samples. This optimization will hopefully be valuable for
researchers aiming to utilize this approach for additional chemical genetic kinase substrate screens
in the future.
Figure 4 continued
vascular area (E) and ESM1 positive area (F) per field of retinal fronts. 8-10 retinas were measured for each group, *P<0,05; **P<0,01; ***P<0,001;
****P<0,0001.
DOI: https://doi.org/10.7554/eLife.46380.010
The following source data and figure supplements are available for figure 4:
Source data 1. Values for quantification of radial expansion (Figure 4B), sprouts per 100 mm (Figure 4C), vascular area (Figure 4E) and ESM1 positive
area (Figure 4F) per field of retinal fronts.
DOI: https://doi.org/10.7554/eLife.46380.011
Figure supplement 1. Autophagy inhibition partially rescues retinal vascular hypersprouting caused by PKA deficiency.
DOI: https://doi.org/10.7554/eLife.46380.012
Figure supplement 1—source data 1. Values for vascular area (Figure 4—figure supplement 1C) and ESM1 positive area (Figure 4—figure supple-
ment 1D) per field of retinal fronts.
DOI: https://doi.org/10.7554/eLife.46380.013
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Figure 5. Autophagy inhibition partially rescues retinal vascular hypersprouting caused by PKA deficiency through reducing endothelial cell number but
not the ratio of proliferation endothelial cells and apoptosis of endothelial cells. (A–D) Mice were injected with tamoxifen from P1 to P3, 50 ml 1 mg/ml
EdU were I.P injected 2 hr before retinas collecting at P6. CD31 and ERG staining of P6 retinas isolated from wtPKA with wtATG5 or ATG5ECKO mice
and dnPKAiEC with wtATG5 or ATG5ECKO mice followed by EdU Click-iT 647 dye labeling. Representative images are shown (A). Quantifications of
Figure 5 continued on next page
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Materials and methods
Key resources table
Reagent
type
(species) or
resource Designation
Source
or reference Identifiers Additional information
Strain,
strain background
(Mus musculus)
Prk
ar1atm2Gsm
PMID: 21533282
Strain,
strain
background
(Mus musculus)
Tg(Cdh
5-cre/ERT2)1Rha
MGI:3848980
Genetic
reagent
(Mus musculus)
ATG5flox/flox PMID: 16625204
Cell line
(human)
HUVEC PromoCell
and freshly
isolated cells
Cell line
(human)
HEK293T ATCC
Transfected
construct
(Mus)
pRRL.CMV.flag-
PKACa
This paper
Transfected
construct
(Mus)
pRRL.CMV.flag-
PKACaM120G
This paper
Transfected
construct
(human)
pECE-M2-
PPP1R12A
Addgene:
31658
Transfected
construct
(human)
EGFPC1-huNF
ATc1EE-WT
Addgene: 24219
Transfected
construct
(human)
pDESTmycDDX17,
pRRL.CMV.f
lag-DDX17
Addgene: 19876
This paper
Transfected
construct
(human)
pMRX-IP/SECFP-h
ATG16L1
pRRL.CMV.
flag- ATG16L1a
Addgene: 58994
This paper
Transfected
construct
(human)
pRRL.CMV.flag-
ATG16L1b
This paper
Continued on next page
Figure 5 continued
endothelial cells (ERG positive cells) (B), proliferating endothelial cells (EdU and ERG positive cells) (C) and ratio of proliferating endothelial cells (EdU
and ERG positive cells/ERG positive cells) (D). 6–9 retinas were measured for each group, *p<0,05; **p<0,01; ***p<0,001; ****p<0,0001. (E–F) Mice
were injected with tamoxifen from P1 to P3, then retinas were collected at P6. CD31 and Cleaved caspase 3 staining of P6 retinas isolated from wtPKA
with wtATG5 or ATG5ECKO mice and dnPKAiEC with wtATG5 or ATG5ECKO mice. Representative images are shown (E). Quantifications of endothelial
apoptosis (F). 6–8 retinas were measured for each group.
DOI: https://doi.org/10.7554/eLife.46380.014
The following source data is available for figure 5:
Source data 1. Values for quantification of endothelial cells (ERG positive cells) (Figure 5B), proliferating endothelial cells (EdU and ERG positive cells)
(figure 5C), ratio of proliferating endothelial cells (EdU and ERG positive cells/ERG positive cells) (Figure 5D) and endothelial apoptosis
(Figure 5F).
DOI: https://doi.org/10.7554/eLife.46380.015
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Continued
Reagent
type
(species) or
resource Designation
Source
or reference Identifiers Additional information
Transfected
construct
(human)
pRRL.CMV.
GFP- ATG5
This paper
Transfected
construct
(human)
pRRL.CMV.flag- AT
G16L1a S268A
This paper
Transfected
construct
(human)
pRRL.CMV.flag- A
TG16L1b S269A
This paper
Transfected
construct
(human)
pRRL.CMV.flag-
ATG16L1b S287A
This paper
Transfected
construct
(human)
pRRL.CMV.flag-
ATG16L1b
S269A and S287A
This paper
Transfected
construct
(human)
pRRL.CMV.GFP-
ATG16L1a
This paper
Transfected
construct
(human)
pRRL.CMV.GFP-
ATG16L1a S268D
This paper
Transfected
construct
(human)
pRRL.CMV.GFP-
ATG16L1b
This paper
Transfected
construct
(human)
pRRL.CMV.GFP-
ATG16L1b S269D
This paper
Transfected
construct
(human)
pLKO.1-TRC
cloning
shRNA vector
Addgene: 10878
Transfected
construct
(human)
pLKO.1-TRC
shPKACa
This paper
Antibody Anti-Thiop
hosphate
ester antibody
[51-8]
Abcam: ab92570 WB 1:5000
Antibody Anti-Thiop
hosphate
ester antibody
[51-8]
Abcam: ab133473 IP
Antibody GAPDH (14C10)
Rabbit mAb
cell
signaling: #2118
WB 1:1000
Antibody Atg16L1 (D6D5)
Rabbit mAb
cell
signaling: #8089
WB 1:1000
Antibody LC3B (D11) XP
Rabbit mAb
cell
signaling: #3868
WB 1:1000
Antibody PKA C-a
Antibody
cell
signaling: #4782
WB 1:1000
Antibody SQSTM1/p62
(D5E2) Rabbit mAb
cell
signaling: #8025
WB 1:1000
Continued on next page
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Continued
Reagent
type
(species) or
resource Designation
Source
or reference Identifiers Additional information
Antibody Phospho-PKA
Substrate
(RRXS*/T*)
(100G7E)
Rabbit mAb
cell
signaling: #9624
WB 1:1000
Antibody GFP Tag
Polyclonal
Antibody
Invitrogen: A11122 WB 1:1000
Antibody goat anti-
Actin(c-11)
Santa
Cruz
Biotechn
ology: sc-1615
WB 1:2000
Antibody ANTI-FLAG
antibody
produced in
rabbit
Sigma: F7425 WB 1:1000
Antibody Monoclonal
ANTI-FLAG M2
antibody
produced in mouse
Sigma: F3165 WB 1:1000
Antibody Anti-rabbit IgG,
HRP-
linked Antibody
cell
signaling: #7074
WB 1:2000
Antibody chicken anti-
goat IgG-HRP
Santa
Cruz Biotech
nology: sc-516086
WB 1:5000
Antibody Peroxidase
AffiniPure Donkey
Anti-Mouse IgG
(H+L)
Jackson Immuno Research: 715-035-151 WB 1:2000
Antibody Isolectin GS-IB4
From Griffonia
simplicifolia, Alexa
Fluor 488
Conjugate
Thermo Fisher: I21411 IF 1:100
Antibody Mouse Endocan/
ESM-1 Antibody
R and D: AF1999 IF 1:100
Antibody Donkey anti-Goat
IgG (H+L) Cross-
Adsorbed
Secondary
Antibody,
Alexa Fluor 555
Thermo Fisher: A21432 IF 1:500
Antibody Rabbit anti-ERG Abcam: ab92513 IF 1:500
Antibody rabbit anti-cleaved
caspase 3
R and D: AF835 IF 1:200
Antibody Rat anti-CD31 BD Pharmingen: BD553370 IF 1:200
IP
Antibody Donkey
anti-Rat IgG
(H+L) Cross-
Adsorbed
Secondary
Antibody,
Alexa Fluor 488
Thermo
Fisher:
A21208
IF 1:500
Continued on next page
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Continued
Reagent
type
(species) or
resource Designation
Source
or reference Identifiers Additional information
Antibody Donkey anti-
Rabbit IgG
(H+L) Cross-
Adsorbed
Secondary
Antibody,
Alexa Fluor 555
Thermo
Fisher:
A31572
IF 1:500
Commercial
assay or kit
Q5 Site-Directed
Mutagenesis Kit
NEB: E0554S
Commercial
assay or kit
Lenti-X p24 Rapid
Titer Kit
Clontech:
632200
Commercial
assay or kit
Pierce Silver
Stain Kit
Thermo Fisher:24600
Commercial
assay or kit
Click-iT EdU Alexa
Fluor 647
Imaging Kit
Thermo fishier:C10340
Chemical
compound, drug
X-tremeGENE HP
DNA transfection
reagent
Roche
Chemical
compound, drug
6-cHe-ATPgS Biolog:C127
Chemical
compound, drug
Sp-8-CPT-
cAMPS
Biolog:C012
Chemical
compound, drug
6-bnz-cAMP Biolog:C009
Software,
algorithm
image J image J
Software,
algorithm
GraphPad Prism 7 GraphPad
Prism 7
Other Recombinant
Protein G Agarose
Invitrogen
Other sheep
anti-Rat IgG-
coupled
Dynabeads
Invitrogen
Cell culture
Human Umbilical Vein Endothelial Cells (HUVECs) were freshly isolated (or purchased from Promo-
cell) and cultured in Endothelial Cell Growth Medium (Ready-to-use) (Promocell), passage 3 to 5
were used for experiments. HEK293T cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM, Thermo Fisher) with 10% Fetal Bovine Serum (FBS, Thermo Fisher) and 50 U/ml penicillin
and 50 mg/ml streptomycin (Thermo Fisher) in 5% CO2 at 37˚C.
Plasmid construction
Lentivirus vector pRRLsin.PPT.CMV.flag.MCS and pRRLsin.PPT.CMV.GFP.MCS were generated by
resctrictional cloning of a sequence coding flag-tag/GFP-tag into the pRRLsin.PPT.CMV.MCS vector
at XbaI and XmaI restriction sites. PKACa gene from mouse, ANKRD40 and ATG5 were amplified
from total RNA extracted from HUVECs and cloned into the pRRLsin.PPT.CMV.flag/GFP.MCS vec-
tor. pECE-M2-PPP1R12A wt, EGFPC1-huNFATc1EE-WT, pDESTmycDDX17, pMRX-IP/SECFP-
hATG16L1 were purchased from Addgene. pDESTmycDDX17, pMRX-IP/SECFP-hATG16L1 and
subcloned to vector pRRLsin.PPT.CMV.flag.MCS. PKACa M120G, ATG16L1a S268A, ATG16L1b
S269A, ATG16L1b S287A, ATG16L1b S269A and S287A were generated by site-directed mutagene-
sis using Q5 Site-Directed Mutagenesis Kit (NEB). ATG5, ATG16L1a, ATG16L1a S268D, ATG16L1b,
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ATG16L1b S269D were cloned into the pRRLsin.PPT.CMV.GFP.MCS vector. pLKO.1-TRC cloning
shRNA vector (addgene) was used to clone PKACa shRNA constructs targeting sequence: TAGATC
TCACCAAGCGCTTTG and TCAAGGACAACTCAAACTTAT.
Lentivirus production and infection
For lentivirus production, HEK293T cells, seeded in 150 mm dishes, were transfected with flag-
tagged or GFP-tagged constructs, psPAX2 and pMD2.G using X-tremeGENE HP (Roche) as transfec-
tion reagent. Medium was changed 12–16 hr after transfection. Lentivirus-containing medium was
collected in 24–48 hr afterwards and filtered through 0.45 filters. Lentivius titers were determined
with Lenti-X p24 Rapid Titer Kit (Clontech). To infect HUVEC, lentivirus (MOI 20–50) and polybrene
(final concentration 8 mg/ml) was added to cells for 18–22 hr, and then the cells were washed with
PBS and replaced the medium with fresh EGM2.
Protein extraction and western blot
Cells were lysed in RIPA buffer contained protease inhibitor cocktail and PhosSTOP (Roche). Protein
concentrations were measured by Pierce BCA Protein Assay Kit. Samples were further diluted with
SDS-loading buffer and SDS-PAGE was performed using NuPAGE 4–12% Bis-Tris Protein Gels (Invi-
trogen). Proteins were tranferred to nitrocellulose membrane with iBlot 2 Dry Blotting System
(Thermo Fisher) or to PVDF membranes by wet blotting. Membranes were blocked with 5% nonfat
milk in TBST and primary antibodies were incubated overnight at 4˚C or 1.5 hr at room temperature.
HRP-conjugated secondary antibodies were diluted and incubated 1 hr at room temperature. Super-
Signal West Pico Chemiluminescent Substrate (Thermo Fisher) was used for imaging. Following anti-
bodies were used: rabbit anti-thiophosphate ester (ab92570,1:5000) was from Abcam, goat anti-b-
actin (sc-1615,1:2000) antibody, chicken anti-goat IgG-HRP (sc-516086,1:5000) were from Santa Cruz
Biotechnology, rabbit anti-GAPDH (#2118,1:1000), rabbit anti-PKACa (#4782,1:1000), rabbit anti-
ATG16L1 (#8089,1:1000), rabbit anti-p62 (#8025,1:1000), rabbit anti-LC3 (#3868,1:1000) antibodies
and anti-rabbit IgG, HRP-linked antibody (#7074,1:2000) were from Cell Signaling, rabbit anti-flag
(F7425,1:1000) and mouse anti-flag (F3165,1:1000) were from Sigma and rabbit anti-GFP
(A11122,1:1000) was from Invitrogen. Peroxidase affinipure donkey anti-mouse IgG (715-035-
151,1:2000) was from Jackson Immuno Research.
Chemical genetic screen and validation of PKA substrates
HUVECs (6 10cm-dishes each containing 1  106 cells) were infected with lentivirus encoding either
flag-PKACa WT (as negative control) or flag-PKACa M120G. 48 hr after infection, cells were stimu-
lated with Sp-8-CPT-cAMPS (Biolog) for 10 min, then lysed in kinase lysis buffer (1% NP40, 142 mM
NaCl, 25 mM Tris-HCl (pH 7.5), 5 mM b-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10
mM MgCl2) with protease inhibitor cocktail on ice for 20 min and spun (16,000g  10 min) to
remove cell debries. 3.5 mM GTP and 350 mM 6-cHe-ATPgS (Biolog) were added to the lysates.
After 30 min incubation at 30˚C, 2.5 mM p-Nitrobenzyl mesylate (PNBM, Abcam) was added and the
reaction was incubated for additional 2 hr at room temperature. PNBM was removed by Zeba Spin
Desalting Columns, 7K MWCO (Thermo Fisher) and samples were washed with IP buffer (1% NP40,
150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 0.5% sodium deoxycholate). The protein fractions were pre-
cleared by incubation with Recombinant Protein G Agarose for one hour at 4˚C. The precleared sam-
ples were then incubated with anti-thiophosphate ester antibody (51-8; Abcam) coupled to
Recombinant Protein G Agarose coupled gently rocking overnight at 4˚C. The agarose beads were
washed four times with IP buffer. 1/30 of the washed beads was boiled in SDS sample loading buffer
for western blot detection or silver staining. The rest samples were used for mass spectrometry
analyze.
For validation of the identified substrates, 293 T cells (1.5  106 on a 6 cm dish) were transfected
with 0.5 mg pRRL PKACa WT or pRRL PKACa M120G and 1.5 mg of indicated candidate substrate
using X-tremeGENE HP DNA transfection reagent (Roche). 30 hr after transfection, cells were stimu-
lated with Sp-8-CPT-cAMPS (Biolog) for 10 min, lysated and treated as described above.
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Silver staining
Silver staining was performed using Pierce Silver Stain Kit (Thermo Fisher,24600) according to the
manufacturer’s protocol. Briefly, the SDS-page gel was washed in ultrapure water and fixed by fixing
solution (30% ethanol,10% acetic acid) for 30 min. After incubating the gel in sensitizer working
solution (provided in the kit) for 1 min, silver stain enhancer (provided in the kit) was added for
another 5 min. Subsequently, the gel was incubated with developer working solution (provided in
the kit) for 2–3 min, before stopping the reaction with stop solution (provided in the kit).
Mass spectrometry to identify new PKA substrates and
phosphorylation sites
For mass spectrometric analysis to identify new PKA substrates, samples were prepared by chemical
genetical approach as described above, each sample was run on a stacking SDS-PAGE collecting all
proteins in a single band. After coomassie blue staining, the minced gel pieces were digested with
trypsin based on Shevchenko et al. (2006) in an automated fashion using a PAL robot (Axel Sem-
rau/CTC Analytics). Samples were measured on an LTQ Orbitrap VELOS mass spectrometer (Thermo
Fisher) connected to a Proxeon nano-LC system (Thermo Fisher). Five microliters of the sample was
loaded on a nano-LC column (0.074  250 mm, 3 mm Reprosil C18; Dr. Maisch) and separated on a
155 min gradient (4%–76% acetonitrile) at a flow rate of 0.25 ml/min and ionized using a Proxeon
ion source. Mass spectrometric acquisition was done at a resolution of 60,000 with a scan range of
200–1,700 m/z in FTMS mode selecting the top 20 peaks for collision-induced dissociation fragmen-
tation. Tandem mass spectrometric scans were measured in ion-trap mode with an isolation width of
2 m/z and a normalized collision energy of 40. Dynamic exclusion was set to 60 s. For data analysis,
the MaxQuant software package version 1.5.2.8 (Cox and Mann, 2008) was used. Carbamidomethy-
lation on cysteine was set as a fixed modification and oxidized methionine, acetylated N-termini and
phosphorylation as variable modifications. An FDR of 0.01 was applied for peptides and proteins
and the Andromeda search (Cox et al., 2011) was performed using a mouse Uniprot database
(August 2014). MS intensities were normalized by the MaxLFQ algorithm implemented in MaxQuant
(Cox et al., 2014). MaxLFQ-normalized intensities among the replicates of the groups to be related
were used for comparison. For downstream analysis R was used to calculate fold changes and
t-statistics.
For mass spectrometric analysis to identify phosphorylatin sites of ATG16L1, purified thiophos-
phorylated ATG16L1 proteins on beads were washed 3 times with 800 ml IP buffer followed by three
times washing with 800 ml digestion buffer (20 mM Tris pH 8.0, 2 mM CaCl2) and dried. The washed
beads were resuspended in 150 ml digestion buffer and incubated for 4 hr with 1 mg trypsin (Prom-
ega, catnr: V5111) at 37 ˚C. Beads were removed, another 1 mg of trypsin was added and proteins
were further digested overnight at 37 ˚C. Peptides were acidified with 1% TFA and purified on Omix
C18 tips (Agilent, catnr. A57003100), dried and re-dissolved in 20 ml loading solvent (0.1% TFA in
water/acetonitrile (98:2, v/v)). Five microliters of the peptide mixture was injected for LC-MS/MS
analysis on an Ultimate 3000 RSLC nano LC (Thermo, Bremen, Germany) in-line connected to a Q
Exactive mass spectrometer (Thermo). Trapping was performed at 10 ml/min for 4 min in loading sol-
vent on a 100 mm internal diameter (I.D.)20 mm trapping column (5 mm beads, C18 Reprosil-HD,
Dr. Maisch, Germany) and the sample was loaded on a reverse-phase column (made in-house, 75 mm
I.D. x 220 mm, 1.9 mm. Peptides were eluted by a linear increase from 2% to 55% solvent B (0.08%
formic acid in water/acetonitrile (2:8, v/v)) over 120 min at a constant flow rate of 300 nl/min. The
mass spectrometer was operated in data-dependent mode, automatically switching between MS
and MS/MS acquisition. Full-scan MS spectra (400–2000 m/z) were acquired at a resolution of 70,000
in the orbitrap analyzer after accumulation to a target value of 3,000,000. The five most intense ions
above a threshold value of 17,500 were isolated (window of 2.0 Th) for fragmentation at a normal-
ized collision energy of 25% after filling the trap at a target value of 50,000 for maximum 80 ms. MS/
MS spectra (200–2000 m/z) were acquired at a resolution of 17,500 in the orbitrap analyzer. Raw LC-
MS/MS data files were searched against the human proteins in the Uniprot/Swiss-Prot database
(database version of September 2017 containing 20,237 human sequences, downloaded from www.
uniprot.org). The mass tolerance for precursor and fragment ions were set to 4.5 and 20 ppm,
respectively, during the main search. Enzyme specificity was set as C-terminal to arginine and lysine,
also allowing cleavage at proline bonds with a maximum of two missed cleavages. Variable
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modifications were set to oxidation of methionine residues, acetylation of protein N-termini, phos-
phorylation and thiophosphorylation of serine, threonine and tyrosine residues. The minimum score
for modified peptides was set to 40. The S-lens RF level was set at 50 and we excluded precursor
ions with single, unassigned and charge states above five from fragmentation selection.
Peptide arrays, Peptide SPOT assay of ATG16L1 phosphorylation sites
screening
Automatic peptide SPOT synthesis was carried out as described previously (Hundsrucker et al.,
2006; Hundsrucker et al., 2010; Maass et al., 2015; Stefan et al., 2007). Fmoc-protected amino
acids (Intavis) and amino-modified acid-stable cellulose membranes with PEG-spacers (Intavis) were
used for peptide spots synthesis on an Intavis ResPep-SL device.
For phosphorylation of the peptides by PKA (Maass et al., 2015), the membranes were activated
in ethanol, blocked in blocking buffer (5% milk in TBS-T: Tris-HCl, 10 mM; NaCl, 150 mM; Tween 20,
0.05%; pH 7.4) for 3 hr at room temperature, and washed twice with incubation buffer (Tris-HCl, 50
mM; MgCl2, 5 mM; ATP, 100 mM). His-tagged recombinant catalytic subunits (vector pET46) were
purified from E. coli (strain Rosetta D3) as described (Maass et al., 2015; Scha¨fer et al., 2013). The
membranes were incubated with the recombinant protein (1 nM) in incubation buffer (1 hr, 30˚C),
washed three times with TBS-T, and phosphorylated serines were detected with PKA phosphosub-
strate antibody directed against the consensus site RRX p(S/T) (Cell Signaling Technology, 100G7E,
rabbit mAB #9624) in blocking buffer overnight at 4˚C (Christian et al., 2011). The membranes were
washed three times with TBS-T, and a secondary horseradish peroxidase (HRP)-coupled donkey anti-
rabbit antibody (#711-036-153; Jackson Immuno Research) was added (3 hr, RT). After three washs
with TBS-T, an ECL system (Immobilon Western substrate, Merck Millipore) and an Odyssey FC
device (Li-Cor ) was used for visualizing phosphorylated serines.
Animal procedures
All animal experimental procedures were approved by the Institutional Animal Care and Research
Advisory Committee of the University of Leuven and performed according to the European guide-
lines. Following mouse strains were used: Prkar1atm2Gsm (Willis et al., 2011), Tg(Cdh5-cre/ERT2)1Rha
(Wang et al., 2010) and ATG5flox/flox (Hara et al., 2006). All animals used in the experiments were
of mixed N/FVB x C57/Bl6 background. For chloroquine rescue retinal angiogenesis experiment,
pups were intraperitoneally injected with 50 ml of 1 mg/ml tamoxifen from postnatal day one (P1) to
P3, and 100 ml of 1.25 mg/ml chloroquine or PBS from P1 to P5. Mice were euthanized at P6, and
dissection and staining of the retinas were performed as described below. For ATG5 deletion in
endothelial cells rescue retinal angiogenesis experiment and apoptosis assay in retinal endothelial
cells, pups were intraperitoneally injected with 50 ml of 1 mg/ml tamoxifen from P1 to P3 and eutha-
nized at P6. For proliferation assay in retinal endothelial cells, 50 ml of 1 mg/ml EdU (Thermo fishier,
C10340) were intraperitoneally injected 2 hr before euthanizing the mice at P6. For endothelial cells
isolation, pups were intraperitoneally injected with 75 ml of 1 mg/ml tamoxifen daily from P7 until
P10 and the mice were euthanized at 8 weeks and endothelial cells were isolated as described
below.
Retinal angiogenesis assay
To analyse retinal angiogenesis, the procedures of isolation and staining of the retinas were per-
formed as published (Pitulescu et al., 2010). Briefly, retinas were dissected in PBS and blocked/per-
meabilized in retina blocking buffer (1% BSA and 0.3% Triton X-100 in PBS) for 1–2 hr at room
temperature. Alexa Fluor 488 conjugated Isolectin GS-IB4 (Invitrogen) diluted in Pblec solution (1
mM MgCl2, 1 mM CaCl2, 0.1 mM MnCl2 and 1% Triton X-100 in PBS) was added to visualize whole-
retina vasculature by incubating overnight at 4˚C, followed by staining for ESM1 (primary goat anti-
ESM1 antibody; R and D Systems). After mounting, images of retinas were taken using a Leica SPE
confocal microscope equipped with a HC PL APO 20X/0.75 IMM CORR CS2 objective or Leica SP8
confocal microscope equipped with a HCX IRAPO L 25X/0.95 W objective. Images were taken at
room temperature using Leica LAS X software and processed with image J software.
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Retinal endothelial proliferation and apoptosis assay
To perform endothlial proliferation and apoptosis assays, mouse eyes were collected at P6 and fixed
for 30 min at room temperature with 4% PFA. Retinas were dissected in PBS and blocked/permeabi-
lized in 1% BSA, 50 mg/ml digitonin in PBS, primary antibodies (rat anti-CD31,BD553370; rabbit anti-
ERG,ab92513; rabbit anti-Cleaved caspase 3,AF835) were incubated overnight at 4˚C and secondary
antibodies (Thermo fisher) were incubated for 2 hr at room temperature. Both antibodies were
diluted in1% BSA, 2% donkey serum, 50 mg/ml digitonin in PBS. The Click-iT Edu cell proliferation kit
(C10340) was used to visualize proliferating endothelial cells. After mounting, images of retinas were
taken using a Leica SPE confocal microscope equipped with a ACS APO 40X/1.15 oil CS objective or
Leica SP8 confocal microscope equipped with a HCX IRAPO L 25X/0.95 W objective. Images were
taken at room temperature using Leica LAS X software and processed with image J software.
Endothelial cell isolation from liver or lung
Livers or lung lobes were collected in dry 10 cm dishes and minced finely with blades for one minute,
and then incubated in 25 ml of pre-warmed Dulbecco modified Eagle medium (4.5 g/L glucose with
L-glutamine) containing 2 mg/mL collagenase (Invitrogen) in 50 ml tubes, gently shaking for 45 min
at 37˚C. Suspensions were passed through a 70 mm cell strainer (VWR) and cells were spun down at
400 g for 8 min at 4˚C. Pellets were resuspended in 10 ml Dulbecco modified Eagle medium contain-
ing 10% FBS, 50 U/ml penicillin and 50 mg/ml streptomycin, passed through 40 mm Nylon cell
strainer (BD Falcon, Cat. No. 352340) and centrifuged at 400 g for 8 min at 4˚C. Cells were resus-
pended in cold DPBS (1 ml/lung and 2 ml/liver), added to sheep anti-Rat IgG-coupled Dynabeads
(Invitrogen) pre-incubated with purified Rat Anti-Mouse CD31 (BD Pharmingen) and incubated at 4˚
C for 20 min. The beads were separated using a magnetic particle concentrator (Dynal MPC-S; Invi-
trogen) and washed with cold DPBS with 0.1% BSA. This washing step was repeated five times after
which cells were lysed in RIPA buffer for Western Blotting.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 7. The one-way ANOVA was used to com-
pare more than two experimental groups.
Acknowledgements
We are grateful to Evy Timmerman and Francis Impens for their help to identify the phosphorylation
sites of ATG16L1 in MS analysis at the VIB proteomics core facility. We are grateful to professor
Chantal Boulanger for providing the ATG5flox/flox mice. This work was supported by grants from the
Fonds voor Wetenschappelijk Onderzoek (FWO) [G.0742.15N to HG]; the Vlaams Instituut voor Bio-
technologie (VIB) Tech watch grant [Q3 2015 to PIN]; the Elsa-Kroener-Stiftung [2014_A26 to HG
and PIN]; the European Research Consortil [ERC Consolidator grant REshape 311719 to HG]; This
work was supported by grants from the German Centre for Cardiovascular Research (DZHK) partner
site Berlin (81XZ100146), the Deutsche Forschungsgemeinschaft (DFG KL1415/7-1 and 394046635-
SFB 1365) and the Bundesministerium fu€r Bildung und Forschung (BMBF; 16GW0179K) to EK.
Additional information
Competing interests
Holger Gerhardt: Reviewing editor, eLife. The other authors declare that no competing interests
exist.
Funding
Funder Grant reference number Author
Europees Fonds voor Regio-
nale Ontwikkeling
G.0742.15N Holger Gerhardt
Else-Kroener Stiftung 2014_A26 Pavel Nedvetsky
Holger Gerhardt
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 20 of 25
Research article Biochemistry and Chemical Biology Cell Biology
European Research Council 311719 REshape Holger Gerhardt
Deutsche Forschungsge-
meinschaft
DFG KL1415/7-1 Enno Klussmann
Deutsche Forschungsge-
meinschaft
394046635 - SFB 1365 Enno Klussmann
Bundesministerium fu¨r Bildung
und Forschung
16GW0179K Enno Klussmann
Vlaams Instituut voor Biotech-
nologie
Tech Watch Q3 2015 Pavel Nedvetsky
Holger Gerhardt
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
Xiaocheng Zhao, Conceptualization, Data curation, Formal analysis, Validation, Investigation,
Visualization, Methodology, Writing—original draft; Pavel Nedvetsky, Conceptualization, Data
curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Project
administration, Writing—review and editing; Fabio Stanchi, Formal analysis, Investigation,
Methodology, Writing—review and editing; Anne-Clemence Vion, Conceptualization, Resources,
Data curation, Investigation, Methodology; Oliver Popp, Kerstin Zu¨hlke, Formal analysis,
Investigation, Methodology; Gunnar Dittmar, Supervision, Methodology; Enno Klussmann,
Conceptualization, Funding acquisition, Investigation, Methodology; Holger Gerhardt,
Conceptualization, Supervision, Funding acquisition, Project administration, Writing—review and
editing
Author ORCIDs
Xiaocheng Zhao https://orcid.org/0000-0002-4048-6813
Anne-Clemence Vion http://orcid.org/0000-0002-2788-2512
Enno Klussmann http://orcid.org/0000-0003-4004-5003
Holger Gerhardt https://orcid.org/0000-0002-3030-0384
Ethics
Animal experimentation: All animal experimental procedures were approved by the Institutional Ani-
mal Care and Research Advisory Committee of the University of Leuven (application P249/2014) and
performed according to the European guidelines.
Decision letter and Author response
Decision letter https://doi.org/10.7554/eLife.46380.021
Author response https://doi.org/10.7554/eLife.46380.022
Additional files
Supplementary files
. Supplementary file 1. Array map of spot-synthesized 25-mer overlapping peptides covering the
entire ATG16L1 protein.
DOI: https://doi.org/10.7554/eLife.46380.016
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.46380.017
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE partner repository with the dataset identifier PXD012975. All data generated or ana-
lysed during this study are included in the manuscript and supporting files. Source data files have
been provided for Figures 3, 4 and 5.
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 21 of 25
Research article Biochemistry and Chemical Biology Cell Biology
The following dataset was generated:
Author(s) Year Dataset title Dataset URL
Database and
Identifier
Dittmar G, Ger-
hardt H
2019 Endothelial PKA targets ATG16L1
to regulate angiogenesis by
limiting autophagy
https://www.ebi.ac.uk/
pride/archive/projects/
PXD012975
PRIDE, PXD012975
References
Alaimo PJ, Shogren-Knaak MA, Shokat KM. 2001. Chemical genetic approaches for the elucidation of signaling
pathways. Current Opinion in Chemical Biology 5:360–367. DOI: https://doi.org/10.1016/S1367-5931(00)
00215-5, PMID: 11470597
Allen JJ, Lazerwith SE, Shokat KM. 2005. Bio-orthogonal affinity purification of direct kinase substrates. Journal
of the American Chemical Society 127:5288–5289. DOI: https://doi.org/10.1021/ja050727t, PMID: 15826144
Allen JJ, Li M, Brinkworth CS, Paulson JL, Wang D, Hu¨bner A, Chou WH, Davis RJ, Burlingame AL, Messing RO,
Katayama CD, Hedrick SM, Shokat KM. 2007. A semisynthetic epitope for kinase substrates. Nature Methods 4:
511–516. DOI: https://doi.org/10.1038/nmeth1048, PMID: 17486086
Anton KA, Sinclair J, Ohoka A, Kajita M, Ishikawa S, Benz PM, Renne T, Balda M, Jorgensen C, Matter K, Fujita
Y. 2014. PKA-regulated VASP phosphorylation promotes extrusion of transformed cells from the epithelium.
Journal of Cell Science 127:3425–3433. DOI: https://doi.org/10.1242/jcs.149674, PMID: 24963131
Banko MR, Allen JJ, Schaffer BE, Wilker EW, Tsou P, White JL, Ville´n J, Wang B, Kim SR, Sakamoto K, Gygi SP,
Cantley LC, Yaffe MB, Shokat KM, Brunet A. 2011. Chemical genetic screen for ampka2 substrates uncovers a
network of proteins involved in mitosis. Molecular Cell 44:878–892. DOI: https://doi.org/10.1016/j.molcel.2011.
11.005, PMID: 22137581
Bullen JW, Tchernyshyov I, Holewinski RJ, DeVine L, Wu F, Venkatraman V, Kass DL, Cole RN, Van Eyk J,
Semenza GL. 2016. Protein kinase A-dependent phosphorylation stimulates the transcriptional activity of
hypoxia-inducible factor 1. Science Signaling 9:ra56. DOI: https://doi.org/10.1126/scisignal.aaf0583,
PMID: 27245613
Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U. 1994. cAMP- and cGMP-dependent protein
kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in
intact human platelets. The Journal of Biological Chemistry 269:14509–14517. PMID: 8182057
Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, Stone CD, Brunt
EM, Xavier RJ, Sleckman BP, Li E, Mizushima N, Stappenbeck TS, Virgin HW. 2008. A key role for autophagy
and the autophagy gene Atg16l1 in mouse and human intestinal paneth cells. Nature 456:259–263.
DOI: https://doi.org/10.1038/nature07416, PMID: 18849966
Cao R, Farnebo J, Kurimoto M, Cao Y. 1999. Interleukin-18 acts as an angiogenesis and tumor suppressor. The
FASEB Journal 13:2195–2202. DOI: https://doi.org/10.1096/fasebj.13.15.2195
Carmi Y, Dotan S, Rider P, Kaplanov I, White MR, Baron R, Abutbul S, Huszar M, Dinarello CA, Apte RN, Voronov
E. 2013. The role of IL-1b in the early tumor cell-induced angiogenic response. The Journal of Immunology 190:
3500–3509. DOI: https://doi.org/10.4049/jimmunol.1202769, PMID: 23475218
Cheng N, Brantley DM, Chen J. 2002. The ephrins and eph receptors in angiogenesis. Cytokine & Growth Factor
Reviews 13:75–85. DOI: https://doi.org/10.1016/S1359-6101(01)00031-4, PMID: 11750881
Cherra SJ, Kulich SM, Uechi G, Balasubramani M, Mountzouris J, Day BW, Chu CT. 2010. Regulation of the
autophagy protein LC3 by phosphorylation. The Journal of Cell Biology 190:533–539. DOI: https://doi.org/10.
1083/jcb.201002108, PMID: 20713600
Christian F, Szasza´k M, Friedl S, Drewianka S, Lorenz D, Goncalves A, Furkert J, Vargas C, Schmieder P, Go¨tz F,
Zu¨hlke K, Moutty M, Go¨ttert H, Joshi M, Reif B, Haase H, Morano I, Grossmann S, Klukovits A, Verli J, et al.
2011. Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with
compartmentalized cAMP signaling in cardiac myocytes. Journal of Biological Chemistry 286:9079–9096.
DOI: https://doi.org/10.1074/jbc.M110.160614, PMID: 21177871
Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. 2011. Andromeda: a peptide search engine
integrated into the MaxQuant environment. Journal of Proteome Research 10:1794–1805. DOI: https://doi.org/
10.1021/pr101065j, PMID: 21254760
Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. 2014. Accurate proteome-wide label-free quantification
by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Molecular & Cellular
Proteomics 13:2513–2526. DOI: https://doi.org/10.1074/mcp.M113.031591, PMID: 24942700
Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass
accuracies and proteome-wide protein quantification. Nature Biotechnology 26:1367–1372. DOI: https://doi.
org/10.1038/nbt.1511, PMID: 19029910
Diamanti MA, Gupta J, Bennecke M, De Oliveira T, Ramakrishnan M, Braczynski AK, Richter B, Beli P, Hu Y,
Saleh M, Mittelbronn M, Dikic I, Greten FR. 2017. Ikka controls ATG16L1 degradation to prevent ER stress
during inflammation. The Journal of Experimental Medicine 214:423–437. DOI: https://doi.org/10.1084/jem.
20161867, PMID: 28082356
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 22 of 25
Research article Biochemistry and Chemical Biology Cell Biology
Du J, Teng RJ, Guan T, Eis A, Kaul S, Konduri GG, Shi Y. 2012. Role of autophagy in angiogenesis in aortic
endothelial cells. American Journal of Physiology-Cell Physiology 302:C383–C391. DOI: https://doi.org/10.
1152/ajpcell.00164.2011, PMID: 22031599
Ferrara N, Gerber H-P, LeCouter J. 2003. The biology of VEGF and its receptors. Nature Medicine 9:669–676.
DOI: https://doi.org/10.1038/nm0603-669, PMID: 12778165
Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML. 2009. Phosphorylation of NF-kappaB p65 at
Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination.
EMBO Reports 10:381–386. DOI: https://doi.org/10.1038/embor.2009.10, PMID: 19270718
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K,
Shima D, Betsholtz C. 2003. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. The
Journal of Cell Biology 161:1163–1177. DOI: https://doi.org/10.1083/jcb.200302047, PMID: 12810700
Geudens I, Gerhardt H. 2011. Coordinating cell behaviour during blood vessel formation. Development 138:
4569–4583. DOI: https://doi.org/10.1242/dev.062323, PMID: 21965610
Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I,
Okano H, Mizushima N. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease
in mice. Nature 441:885–889. DOI: https://doi.org/10.1038/nature04724, PMID: 16625204
Hellstro¨m M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N,
Yoon K, Rossant J, Iruela-Arispe ML, Kale´n M, Gerhardt H, Betsholtz C. 2007. Dll4 signalling through Notch1
regulates formation of tip cells during angiogenesis. Nature 445:776–780. DOI: https://doi.org/10.1038/
nature05571, PMID: 17259973
Hundsrucker C, Krause G, Beyermann M, Prinz A, Zimmermann B, Diekmann O, Lorenz D, Stefan E, Nedvetsky
P, Dathe M, Christian F, McSorley T, Krause E, McConnachie G, Herberg FW, Scott JD, Rosenthal W,
Klussmann E. 2006. High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase
A-anchoring disruptor peptides. Biochemical Journal 396:297–306. DOI: https://doi.org/10.1042/BJ20051970,
PMID: 16483255
Hundsrucker C, Skroblin P, Christian F, Zenn HM, Popara V, Joshi M, Eichhorst J, Wiesner B, Herberg FW, Reif B,
Rosenthal W, Klussmann E. 2010. Glycogen synthase kinase 3beta interaction protein functions as an A-kinase
anchoring protein. Journal of Biological Chemistry 285:5507–5521. DOI: https://doi.org/10.1074/jbc.M109.
047944, PMID: 20007971
Hunter T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.
Cell 80:225–236. DOI: https://doi.org/10.1016/0092-8674(95)90405-0, PMID: 7834742
Hwang CY, Lee C, Kwon KS. 2009. Extracellular signal-regulated kinase 2-dependent phosphorylation induces
cytoplasmic localization and degradation of p21Cip1. Molecular and Cellular Biology 29:3379–3389.
DOI: https://doi.org/10.1128/MCB.01758-08, PMID: 19364816
Kennelly PJ, Krebs EG. 1991. Consensus sequences as substrate specificity determinants for protein kinases and
protein phosphatases. The Journal of Biological Chemistry 266:15555–15558. PMID: 1651913
Kim J, Kim YH, Kim J, Park DY, Bae H, Lee DH, Kim KH, Hong SP, Jang SP, Kubota Y, Kwon YG, Lim DS, Koh GY.
2017. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. Journal of Clinical
Investigation 127:3441–3461. DOI: https://doi.org/10.1172/JCI93825, PMID: 28805663
Kuma A, Mizushima N, Ishihara N, Ohsumi Y. 2002. Formation of the approximately 350-kDa Apg12-Apg5.
Apg16 multimeric complex, mediated by Apg16 oligomerization, is essential for autophagy in yeast. Journal of
Biological Chemistry 277:18619–18625. DOI: https://doi.org/10.1074/jbc.M111889200, PMID: 11897782
Lee MY, Luciano AK, Ackah E, Rodriguez-Vita J, Bancroft TA, Eichmann A, Simons M, Kyriakides TR, Morales-
Ruiz M, Sessa WC. 2014. Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic
substrates. PNAS 111:12865–12870. DOI: https://doi.org/10.1073/pnas.1408472111, PMID: 25136137
Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL, Lewis J. 2007. Endothelial signalling by
the Notch ligand Delta-like 4 restricts angiogenesis. Development 134:839–844. DOI: https://doi.org/10.1242/
dev.003244, PMID: 17251261
Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132:27–42. DOI: https://doi.org/10.
1016/j.cell.2007.12.018, PMID: 18191218
Liang P, Jiang B, Li Y, Liu Z, Zhang P, Zhang M, Huang X, Xiao X. 2018. Autophagy promotes angiogenesis via
AMPK/Akt/mTOR signaling during the recovery of heat-denatured endothelial cells. Cell Death & Disease 9:
1152. DOI: https://doi.org/10.1038/s41419-018-1194-5, PMID: 30455420
Liu J, Wada Y, Katsura M, Tozawa H, Erwin N, Kapron CM, Bao G, Liu J. 2018. Rho-Associated Coiled-Coil kinase
(ROCK) in molecular regulation of angiogenesis. Theranostics 8:6053–6069. DOI: https://doi.org/10.7150/thno.
30305, PMID: 30613282
Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ. 2007. Delta-like
ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. PNAS 104:3219–3224.
DOI: https://doi.org/10.1073/pnas.0611206104, PMID: 17296940
Lu Q, Yao Y, Hu Z, Hu C, Song Q, Ye J, Xu C, Wang AZ, Chen Q, Wang QK. 2016. Angiogenic factor AGGF1
activates autophagy with an essential role in therapeutic angiogenesis for heart disease. PLOS Biology 14:
e1002529. DOI: https://doi.org/10.1371/journal.pbio.1002529, PMID: 27513923
Maass PG, Aydin A, Luft FC, Scha¨chterle C, Weise A, Stricker S, Lindschau C, Vaegler M, Qadri F, Toka HR,
Schulz H, Krawitz PM, Parkhomchuk D, Hecht J, Hollfinger I, Wefeld-Neuenfeld Y, Bartels-Klein E, Mu¨hl A, Kann
M, Schuster H, et al. 2015. PDE3A mutations cause autosomal dominant hypertension with brachydactyly.
Nature Genetics 47:647–653. DOI: https://doi.org/10.1038/ng.3302, PMID: 25961942
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 23 of 25
Research article Biochemistry and Chemical Biology Cell Biology
Manni S, Mauban JH, Ward CW, Bond M. 2008. Phosphorylation of the cAMP-dependent protein kinase (PKA)
regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in
cardiac cells. Journal of Biological Chemistry 283:24145–24154. DOI: https://doi.org/10.1074/jbc.M802278200,
PMID: 18550536
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. 2002. The protein kinase complement of the human
genome. Science 298:1912–1934. DOI: https://doi.org/10.1126/science.1075762, PMID: 12471243
Matsushita M, Suzuki NN, Obara K, Fujioka Y, Ohsumi Y, Inagaki F. 2007. Structure of Atg5.Atg16, a complex
essential for autophagy. Journal of Biological Chemistry 282:6763–6772. DOI: https://doi.org/10.1074/jbc.
M609876200, PMID: 17192262
Mizushima N, Noda T, Ohsumi Y. 1999. Apg16p is required for the function of the Apg12p-Apg5p conjugate in
the yeast autophagy pathway. The EMBO Journal 18:3888–3896. DOI: https://doi.org/10.1093/emboj/18.14.
3888, PMID: 10406794
Mizushima N, Kuma A, Kobayashi Y, Yamamoto A, Matsubae M, Takao T, Natsume T, Ohsumi Y, Yoshimori T.
2003. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the
Apg12-Apg5 conjugate. Journal of Cell Science 116:1679–1688. DOI: https://doi.org/10.1242/jcs.00381,
PMID: 12665549
Mizushima N. 2010. The role of the Atg1/ULK1 complex in autophagy regulation. Current Opinion in Cell
Biology 22:132–139. DOI: https://doi.org/10.1016/j.ceb.2009.12.004, PMID: 20056399
Montalvo J, Spencer C, Hackathorn A, Masterjohn K, Perkins A, Doty C, Arumugam A, Ongusaha PP,
Lakshmanaswamy R, Liao JK, Mitchell DC, Bryan BA. 2013. ROCK1 & 2 perform overlapping and unique roles
in angiogenesis and angiosarcoma tumor progression. Current Molecular Medicine 13:205–219. DOI: https://
doi.org/10.2174/156652413804486296, PMID: 22934846
Murthy A, Li Y, Peng I, Reichelt M, Katakam AK, Noubade R, Roose-Girma M, DeVoss J, Diehl L, Graham RR, van
Lookeren Campagne M. 2014. A crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3.
Nature 506:456–462. DOI: https://doi.org/10.1038/nature13044, PMID: 24553140
Nedvetsky PI, Zhao X, Mathivet T, Aspalter IM, Stanchi F, Metzger RJ, Mostov KE, Gerhardt H. 2016. cAMP-
dependent protein kinase A (PKA) regulates angiogenesis by modulating tip cell behavior in a Notch-
independent manner. Development 143:3582–3590. DOI: https://doi.org/10.1242/dev.134767, PMID: 277027
86
Neto F, Klaus-Bergmann A, Ong YT, Alt S, Vion AC, Szymborska A, Carvalho JR, Hollfinger I, Bartels-Klein E,
Franco CA, Potente M, Gerhardt H. 2018. YAP and TAZ regulate adherens junction dynamics and endothelial
cell distribution during vascular development. eLife 7:e31037. DOI: https://doi.org/10.7554/eLife.31037,
PMID: 29400648
Niswender CM, Ishihara RW, Judge LM, Zhang C, Shokat KM, McKnight GS. 2002. Protein engineering of
protein kinase A catalytic subunits results in the acquisition of novel inhibitor sensitivity. Journal of Biological
Chemistry 277:28916–28922. DOI: https://doi.org/10.1074/jbc.M203327200, PMID: 12034735
Pitulescu ME, Schmidt I, Benedito R, Adams RH. 2010. Inducible gene targeting in the neonatal vasculature and
analysis of retinal angiogenesis in mice. Nature Protocols 5:1518–1534. DOI: https://doi.org/10.1038/nprot.
2010.113, PMID: 20725067
Pola R, Ling LE, Silver M, Corbley MJ, Kearney M, Blake Pepinsky R, Shapiro R, Taylor FR, Baker DP, Asahara T,
Isner JM. 2001. The morphogen sonic hedgehog is an indirect angiogenic agent upregulating two families of
angiogenic growth factors. Nature Medicine 7:706–711. DOI: https://doi.org/10.1038/89083, PMID: 11385508
Potente M, Gerhardt H, Carmeliet P. 2011. Basic and therapeutic aspects of angiogenesis. Cell 146:873–887.
DOI: https://doi.org/10.1016/j.cell.2011.08.039, PMID: 21925313
Profirovic J, Gorovoy M, Niu J, Pavlovic S, Voyno-Yasenetskaya T. 2005. A novel mechanism of G protein-
dependent phosphorylation of vasodilator-stimulated phosphoprotein. Journal of Biological Chemistry 280:
32866–32876. DOI: https://doi.org/10.1074/jbc.M501361200, PMID: 16046415
Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, Tanaka
K, Kawai T, Tsujimura T, Takeuchi O, Yoshimori T, Akira S. 2008. Loss of the autophagy protein Atg16L1
enhances endotoxin-induced IL-1beta production. Nature 456:264–268. DOI: https://doi.org/10.1038/
nature07383, PMID: 18849965
Satyanarayana A, Gudmundsson KO, Chen X, Coppola V, Tessarollo L, Keller JR, Hou SX. 2010. RapGEF2 is
essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. Blood 116:2921–2931.
DOI: https://doi.org/10.1182/blood-2010-01-262964, PMID: 20595512
Scha¨fer G, Milic´ J, Eldahshan A, Go¨tz F, Zu¨hlke K, Schillinger C, Kreuchwig A, Elkins JM, Abdul Azeez KR, Oder
A, Moutty MC, Masada N, Beerbaum M, Schlegel B, Niquet S, Schmieder P, Krause G, von Kries JP, Cooper
DM, Knapp S, et al. 2013. Highly functionalized terpyridines as competitive inhibitors of AKAP-PKA
interactions. Angewandte Chemie International Edition 52:12187–12191. DOI: https://doi.org/10.1002/anie.
201304686, PMID: 24115519
Seto S-W, Chang D, Jenkins A, Bensoussan A, Kiat H. 2016. Angiogenesis in ischemic stroke and angiogenic
effects of chinese herbal medicine. Journal of Clinical Medicine 5:56. DOI: https://doi.org/10.3390/jcm5060056
Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. 2006. In-gel digestion for mass spectrometric
characterization of proteins and proteomes. Nature Protocols 1:2856–2860. DOI: https://doi.org/10.1038/
nprot.2006.468, PMID: 17406544
Shimizu T, Fukumoto Y, Tanaka S, Satoh K, Ikeda S, Shimokawa H. 2013. Crucial role of ROCK2 in vascular
smooth muscle cells for hypoxia-induced pulmonary hypertension in mice. Arteriosclerosis, Thrombosis, and
Vascular Biology 33:2780–2791. DOI: https://doi.org/10.1161/ATVBAHA.113.301357, PMID: 24135024
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 24 of 25
Research article Biochemistry and Chemical Biology Cell Biology
Song H, Pu J, Wang L, Wu L, Xiao J, Liu Q, Chen J, Zhang M, Liu Y, Ni M, Mo J, Zheng Y, Wan D, Cai X, Cao Y,
Xiao W, Ye L, Tu E, Lin Z, Wen J, et al. 2015. ATG16L1 phosphorylation is oppositely regulated by CSNK2/
casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/
reoxygenation. Autophagy 11:1308–1325. DOI: https://doi.org/10.1080/15548627.2015.1060386, PMID: 260
83323
Sorbara MT, Ellison LK, Ramjeet M, Travassos LH, Jones NL, Girardin SE, Philpott DJ. 2013. The protein
ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an
autophagy-independent manner. Immunity 39:858–873. DOI: https://doi.org/10.1016/j.immuni.2013.10.013,
PMID: 24238340
Stefan E, Wiesner B, Baillie GS, Mollajew R, Henn V, Lorenz D, Furkert J, Santamaria K, Nedvetsky P,
Hundsrucker C, Beyermann M, Krause E, Pohl P, Gall I, MacIntyre AN, Bachmann S, Houslay MD, Rosenthal W,
Klussmann E. 2007. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved
in the regulation of vasopressin-mediated water reabsorption in renal principal cells. Journal of the American
Society of Nephrology 18:199–212. DOI: https://doi.org/10.1681/ASN.2006020132, PMID: 17135396
Suchting S, Freitas C, le Noble F, Benedito R, Bre´ant C, Duarte A, Eichmann A. 2007. The notch ligand Delta-like
4 negatively regulates endothelial tip cell formation and vessel branching. PNAS 104:3225–3230. DOI: https://
doi.org/10.1073/pnas.0611177104, PMID: 17296941
Ubersax JA, Ferrell JE. 2007. Mechanisms of specificity in protein phosphorylation. Nature Reviews Molecular
Cell Biology 8:530–541. DOI: https://doi.org/10.1038/nrm2203, PMID: 17585314
Vion AC, Alt S, Klaus-Bergmann A, Szymborska A, Zheng T, Perovic T, Hammoutene A, Oliveira MB, Bartels-Klein
E, Hollfinger I, Rautou PE, Bernabeu MO, Gerhardt H. 2018. Primary cilia sensitize endothelial cells to BMP and
prevent excessive vascular regression. The Journal of Cell Biology 217:1651–1665. DOI: https://doi.org/10.
1083/jcb.201706151, PMID: 29500191
Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, McNamara E, Eastham-Anderson J, Gould S, Harris
SF, Ndubaku C, Ye W. 2015. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
Nature 519:425–430. DOI: https://doi.org/10.1038/nature14323, PMID: 25799996
Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. 2003. IL-1 is
required for tumor invasiveness and angiogenesis. PNAS 100:2645–2650. DOI: https://doi.org/10.1073/pnas.
0437939100, PMID: 12598651
Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U,
Lu¨thi U, Barberis A, Benjamin LE, Ma¨kinen T, Nobes CD, Adams RH. 2010. Ephrin-B2 controls VEGF-induced
angiogenesis and lymphangiogenesis. Nature 465:483–486. DOI: https://doi.org/10.1038/nature09002
Willis BS, Niswender CM, Su T, Amieux PS, McKnight GS. 2011. Cell-type specific expression of a dominant
negative PKA mutation in mice. PLOS ONE 6:e18772. DOI: https://doi.org/10.1371/journal.pone.0018772,
PMID: 21533282
Xing Y, Tian Y, Kurosawa T, Matsui S, Touma M, Wu Q, Sugimoto K. 2016. Inhibition of blood vessel formation in
tumors by IL-18-polarized M1 macrophages. Genes to Cells 21:287–295. DOI: https://doi.org/10.1111/gtc.
12329, PMID: 26791003
Yang S, Chen X-qi, Lu H-shan, Li Z-ying, Lin T-yan. 2010. Interleukin-18 suppresses angiogenesis and
lymphangiogenesis in implanted lewis lung Cancer. Chinese Journal of Cancer Research 22:303–309.
DOI: https://doi.org/10.1007/s11670-010-0303-5
Zhao et al. eLife 2019;8:e46380. DOI: https://doi.org/10.7554/eLife.46380 25 of 25
Research article Biochemistry and Chemical Biology Cell Biology
